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10 Optical coherence tomography (OCT) is fast emerging as an additional non-interventional modality for skin
11 tumor detection and diagnosis. A master/slave flying spot OCT configuration was assembled to detect periocular
12 basal cell carcinomas (BCC). A swept source at 1300 nm and sweeping speed of 50 kHz were used. A three-step
13 process was involved. First, 384 channeled spectra using a mirror were stored for 384 optical path differences at
14 the master stage. Then, the stored channeled spectra (masks) were correlated with the channeled spectrum from
15 the BCC tissue to produce 384 en face OCT images (200 × 200 pixels) for the optical path difference values used
16 to acquire the masks. Finally, these en face slices were stacked to form a volume to cross-reference BCC tumor
17 margins in the orthogonal plane. Per each eyelid sample, several en face images of 200 × 200 lateral pixels are
18 produced in the time to scan laterally a complete raster of 1.6 s. Combination of the en face views with the
19 cross-sectioning views allow for better discrimination of BCCs comparable to using cross-sectional imaging alone,
20 as previously reported using the conventional fast-Fourier-transform–based OCT techniques. © 2016 Optical
Society of America




24 Basal cell carcinoma (BCC) is the most common form of skin
25 cancer in Caucasians [1] and accounts for 80%–90% of all eye-
26 lid malignancies [2,3]. It is estimated that there are 53,000 new
27 BCC cases diagnosed in the UK yearly [4]. The gold standard
28 for tumor diagnosis involves surgical biopsy for histological
29 analysis [5]. To reduce patient morbidity from surgery, non-
30 invasive methods of diagnosis and determining tumor margins
31 have been investigated in recent years. They include reflectance
32 confocal microscopy (RCM) [6], high frequency ultrasound
33 (HFUS) [7], multispectral imaging [8], multiphoton micros-
34 copy [9], the fluorescent technique [10], confocal scanning
35 laser microscopy (CSLM) [11], and optical coherence tomog-
36 raphy (OCT) [12,13]. Although these technologies provide
37 valuable information, they are not yet widely adopted by main-
38 stream health care professionals to provide the high level of cer-
39 tainty essential for accurate treatment. None of these emerging
40 techniques have been used solely on their own or proved to be
41 superior to the gold standard. These new techniques are often
42 used to bridge the gap of limitation on established technologies,
43 demanding new imaging systems with better penetration depth
44and sensitivity. Nevertheless, recent literature has suggested
45that OCT in en face imaging mode presents the potential
46for improved diagnostic specificity of BCC morphology com-
47pared with clinical assessment and dermoscopy alone [14,15].
48For this reason, we have developed an en face optical coher-
49ence tomography (OCT) system powered with our enhanced
50master/slave (MS) technique [16]. Compared to conventional
51fast Fourier transform (FFT)-based OCT, the MS technique is
52tolerant to the non-uniformities in the modulation frequency
53of the spectra acquired, as well as to dispersion in the interfer-
54ometer [17]. Therefore, the MS technique allows achievement
55of the theoretical expected parameters for the sensitivity and for
56the axial resolution as determined by the bandwidth of the sys-
57tem and by the spectral domain principle. The MS technique
58leads to attainment of such values with no need for resampling
59of data. In conventional FFT-based OCT, the axial resolution
60and sensitivity are as good as the resampling/data linearization
61methods, which generally operate well at shallow depths only.
62Additionally, the MS technique gives direct access to informa-
63tion from selected depths, allowing the real-time display of one
64or more en face OCT images from such depths [18]. The MS
65method has been applied to OCT imaging of the eye fundus,
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66 and by harnessing the power of graphic cards, real-time produc-
67 tion of en face images was made possible [19].
68 This is a pilot study aiming to correlate the histological fea-
69 tures of periocular BCC to features seen on the OCT scan using
70 the MS technique. To the best of our knowledge, this is the first
71 pilot study using the master/slave OCT technique for imaging
72 periocular BCCs. Prior to this, three other studies to image
73 BCC were conducted by our group using dual-wavelength
74 (840 and 1300 nm) time domain (TD)-OCT [20], FFT-based
75 OCT [21], and dynamic focus (DF)-OCT [22]. Based on the
76 experience we gathered from these three tests, we identified that
77 it is essential in performing accurate correlations with histology
78 data to acquire high-resolution OCT images and correctly
79 identify the margins of any skin lesion precisely. On the wave-
80 length selection, we identified that light at 1300 nm suffers less
81 scattering in tissue, thus providing better signal strength
82 compared to 850 nm when used for imaging BCC [19–23].
83 Independent to our group’s research, the use of 1300 nm for
84 OCT imaging was further documented by the study of BCC
85 that employs a combined RCM/OCT system for ex vivo
86 imaging [24]. The data processing of OCT signals is based
87 on the conventional FFT-based technique. In contrast to the
88 MS technique, dispersion compensation and interpolation
89 are employed. The resulting set of 512 OCT raster images, us-
90 ing their method, could be acquired in 13 s. While the RCM
91 channel delivers en face images, the OCT is performed in cross
92 section. Single en face images are inferred by software cut of
93 volumes of A-scans and are placed in comparison with the
94 RCM images.
95 Another study employed a commercial 20 kHz tunable laser
96 to produce 120 stack OCT images of size 6 mm × 6 mm in
97 between 10–20 s [25].
98 None of the OCT systems referenced above are capable of
99 producing en face images in real time.
100 The use of high-definition OCT as an auxiliary diagnostic
101 tool to histology has received an overwhelming positive re-
102 sponse by clinicians, as evidenced by a study that looked
103 into the effectiveness of locating BCC with OCT. This was
104 compared to histology analysis involving both experienced
105 and inexperienced dermatologists [26]. We drew inspiration
106 from these state-of-the-art research studies in developing our
107 master/slave OCT system, with an aim to offer simplified, more
108 robust image display in a shorter time.
109 2. METHODS AND MATERIALS
110 A. Master/Slave OCT
111 The schematic diagram of the MS-OCT system assembled is
112 shown in Fig. 1. Light is emitted from a swept source (SS) op-
113 erating at 1310 nm central wavelength with a 100 nm sweeping
114 range, 50 kHz sweeping speed, and 15 mW output power
115 (model SSOCT-1310, Axsun Technology, Massachusetts,
116 USA). An interferometer, using two directional couplers DC1
117 and DC2, was assembled. The light from the source enters
118 the first directional coupler (DC1, model FOBC-2-1310-20,
119 AFW Technology, Australia) with a splitting ratio of 80∶20.
120 One output delivers 80% of light intensity into the reference
121 arm, and 20% of light into the object arm.
122In the object arm, the interface optics includes an achro-
123matic lens (CM) to collimate the output beam of the fiber,
124four lenses for beam expansion (L1-L4, f  75 mm, AC-
125127-030-C, Thorlabs), and a scan lens (SL). The SL is an
126OCT-optimized microscope objective (LSM03, 5 × ,
127Thorlabs). For a 4 mm beam diameter incident on the SL,
128transversal resolution of the spot on the sample is 15 μm.
129The transversal resolution obtained was verified by imaging
130a USAF 1951 resolution target. Two galvo-scanners are in-
131stalled in the object arm, denoted as GX (frame) and GY (line)
132in Fig. 1.
133Both GX and GY are driven with triangular ramps. Since SS
134has a tuning frequency of 50 kHz, each of the 200 lateral pixels
135are acquired within 20 μs. GX is driven with a triangular signal,
136where each ramp duration is 20 μs∕pixel × 200 pixels  4 ms,
137with every other ramp discarded, so at a frequency of 125 Hz.
138The frame scanner GY is driven with a triangular signal,
139which for 200 lines requires 1.6 s. With a measured transversal
140resolution of 15 μm, the lateral image size is limited to
1413 mm × 3 mm. A single ramp of the frame signal is used for
142data acquisition, while the other ramp is used for data transfer
143to the GPU and data processing. As a result, the time needed
144to acquire each 2D en face dataset of 200 × 200  40; 000
145channeled spectra is 1.6 s.
146The light into the reference arm is reflected off a set of mir-
147rors (M1, M2), then into the second directional coupler (DC2,
148model FOBC-2-1310-50, AFW Technology, Australia), where
149it is combined with the signal from the object arm to produce
150interference patterns. The outputs of the DC2 are connected to
151the photodetectors PD1 and PD2 of a balance photodetector
152module (model BPD-200, Santec, Japan, 200 MHz). This
F1:1Fig. 1. OCT system configuration (GX , GY , galvo scanners; L1, L2,
F1:2L3, L4, lenses; SL, scan lens; M1,M2, mirrors; CM, free-space to fiber
F1:3coupler; MLS, motorized linear stage; DC, directional coupler; PD1,
F1:4PD2, InGaAs photodiodes; Ms, mirror used at the master stage, to be
F1:5replaced with the BCC specimen at the Slave stage).
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153 signal is sent to a digitizer (Alazartech, Canada, model
154 ATS9350, 500 MB/s). This is embedded into a PC with an
155 Intel Xeon processor (model E5646, 2.4 GHz, 6 cores) and
156 a GPU card (GeForce GTX 780 Ti), loaded with a custom
157 64-bit LabVIEW 2014 program to display simultaneously
158 en face images from 40 different depths [28,29].
159 The imaging process using the master/slave (MS) method is
160 a two-step process. First, at the master stage, a mirror (MS) is
161 placed in lieu of the BCC specimen in the focal plane of SL. A
162 set of 384 channeled spectra (masks), are collected and stored.
163 The masks are acquired for MLS positions separated by 10 μm
164 steps using a motorized translation stage, MLS (model MFA-
165 CC, repeatability 0.3 μm, speed 2.5 mm/s, Newport) driven by
166 a motion controller (ESP301, Newport). These masks re-
167 present the channeled spectra at the OCT interferometer out-
168 put for 384 values obtained by equivalently displacing the
169 mirror MS by 5 μm. Thus, with 384 masks, an axial depth
170 range of 1.8 mm in air is achieved.
171 A special program was created to allow quick acquisition of
172 masks by shifting the MLS to a new incremented position by
173 the chosen differential interval (10 μm), followed by time to
174 wait for mechanical vibrations to settle and then followed by
175 the storage of mask for that position, then moved to the next
176 position, and so on. The whole process takes less than 5 min
177 and once masks are collected, the process does not need to be
178 repeated. Collection of masks is performed with no voltage ap-
179 plied to the two galvo-scanners, i.e., using the optical beam
180 on-axis.
181 The second stage (slave) involves imaging the BCC speci-
182 men that replaces the mirror MS. Each BCC specimen is posi-
183 tioned in front of the SL. 384 en face images are obtained by
184correlating the 384 masks with the acquired channeled spectra
185of the BCC tissue, but a reduced number of such images is
186displayed, in this case 40. Figure 2 shows a typical screen of
187the raster displayed by the MS technique. Three categories
188of images are simultaneously presented and they are refreshed
189simultaneously: (a) en face OCT images at 40 simultaneous
190depths, (b) two cross-sectional images, and (c) a compound im-
191age to help with guidance, made from the average of the 40 en
192face images displayed. The en face OCT images and the com-
193pound image have 200 pixels × 200 pixels while the cross-sec-
194tional OCT images have 200 pixels lateral and 384 pixels in
195depth (along the vertical axis, equal to the number of masks).
196The differential distance between the numbers of en face images
197displayed, as well as the depth of the first en face images in the
198left corner, can be adjusted with cursors on-screen (not shown,
199but similar to the procedure detailed in [28]).
200The compound display was found useful in adjusting
201the relative position of the specimens in front of the scan lens
202SL. Here this uses the 40 images displayed; however, this
203can be modified to use any number in any order of the
204398 en face images generated by the end of each scanning
205frame.
206Each category of images is produced using a special program
207developed in CUDA. The simultaneous display of the three
208categories of images takes advantage of methods developed
209in previous reports [22,29], to speed up the processing of com-
210parison operation at the core of the MS technique to the level
211where it can compete with the FFT-based OCT method, while
212maintaining the other MS advantages (tolerance to dispersion
213and tuning nonlinearities with implications in achieving high
214axial resolution and better sensitivity).
F2:1 Fig. 2. Illustration of master/slave raster made from 3 categories of images. (a) 40 en face OCT images separated axially by 5 μm (measured in air),
F2:2 (b) two cross-sectional OCT images acquired from two orthogonal orientations, and (c) an average of the en face images displayed for guidance.
F2:3 The horizontal size of all images and the vertical size of en face OCT images: 3 mm × 3 mm. The vertical size of the two cross-sectional images is
F2:4 3 mm × 1.5 mm (measured in air). The en face images have 200 pixels × 200 pixels while the cross-sectional images 200 pixels × 300 pixels.
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215 The axial resolution of the system is determined by the
216 tuning bandwidth of the optical source. With a SS of
217 Δλ  100 nm bandwidth, we can expect an axial resolution
218 of around 7.5 μm.
219 Histology data are collected in the cross-section plane; there-
220 fore, to compare and correlate suspected BCC features side by
221 side, we need to prepare such cuts from the en face images
222 produced by the MS technique. Therefore, for subsequent
223 analysis, the en face slices acquired are stacked to form a 3D
224 volume. A slice was cut orthogonally to the en face surface
225 to produce a cross-sectional OCT image, as shown in Fig. 3.
226 B. Tissue Imaging
227 Three consecutive patients over the age of 18 with a biopsy-
228 proven periocular nodular BCC, without previous eyelid sur-
229 gery, were enrolled into the study. The study protocol was
230 approved by the Research and Development Department of
231 the Maidstone and Tunbridge Wells NHS Trust and also
232 by the Ethics Committee at the School of Physical Sciences,
233 University of Kent. Informed consent was obtained from the
234 participants.
235 All BCC lesions were surgically excised with predetermined
236 2 mm margins of normal skin. The orientation of each speci-
237 men was specified by using 6/0 silk sutures of various lengths to
238 mark 3 of the margins of the lesion. The excised specimens
239 were placed in 10% neutral buffered formalin and transported
240 from Maidstone Hospital to the University of Kent within 3 h
241of excision for OCT imaging. For purpose of image acquisition,
242the BCC tissue was placed on a transparent microscope glass
243slice, with its superior margin aligned to the horizontal direc-
244tion of the optical beam axis at the microscope focus of the
245OCT machine. After OCT imaging was completed, the spec-
246imens were placed back into 10% neutral buffered formalin
247and transported to the Maidstone Hospital Histology
248Department the same day.
249C. Histology Analysis
250The specimens were allowed to fix in 10% neutral buffered
251formalin for 24 h and then “bread sliced” at 2 mm intervals
252at 90 deg to the skin surface, retaining orientation as
253denoted by the marking sutures. Each slice was processed
254and paraffin-embedded with serial sections cut at 2 μm inter-
255vals, then mounted on glass slides stained with haematoxylin
256and eosin, and viewed in a conventional light microscope.
257Photomicrographs were captured for comparison with OCT
258images and correlation undertaken by identification of the
259matching features of the OCT and histology images under
260supervision of two of the authors (JS and CC).
2613. RESULTS
262The three separate excised BCC specimen biopsy tissues from
263the three patients were imaged using the MS-OCT system.
264Each sample has been marked Case 1, Case 2, and Case 3,
265respectively. To allow comparison to histology data, we as-
266sembled the en face images into a 3D volume. A cross-sectional
267OCT image was then sliced orthogonally to the volume surface.
268Using this method, 200 cross-sectional images were recon-
269structed at different lateral positions. We ran our algorithm
270through all these images from the center of the sample to locate
271possible BCC features contained within each of the cross-sec-
272tional images. Diagnosis of BCC via OCT correlation requires
273demarcation of tumor margins to determine BCC invasion,
274and visual interpretation of morphological features as reported
275in pathology-to-OCT correlation studies [30–33].
276Histology images of Case 1 using an Olympus BX50 micro-
277scope are shown in Fig. 4. The haematoxyphilic (purple) areas
278equate to lobules and strands of BCC. The eosinophilic (pink)
279areas are supporting stroma and normal dermis. The corre-
280sponding OCT cross sections are shown in Fig. 5. The areas
281containing BCCs are compared against the marked area in
F3:1 Fig. 3. Illustration of assembling cross-sectional scans from en face
F3:2 images. En face images are delivered by the MS-OCT technique.
F4:1 Fig. 4. Histology images of the nodular BCC corresponding to tissue sample of Case 1. The images show tumor lobules that correspond to
F4:2 honeycomb structures. The lateral size × depth size of left image is 5 mm × 3 mm. The middle image shows an enlarged view of the white boxed
F4:3 region in the left image. The right image shows an enlarged view of the black box area in the left image. Magnification: left ×10, middle ×20, and
F4:4 right ×100.
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282 the histology image. En face images taken at 30 μm axial in-
283 terval from each other (measured in air), showing features at
284 depths of 450, 480, and 510 μm from the top of the sample
285 are shown in Fig. 6. The corresponding BCC areas are notice-
286 able with several dark spots surrounded by bright regions.
287 A more extensive type of BCC was spotted from another
288 region of Case 1 as shown in Fig. 7. The tumors spread around
289 in a non-uniformed pattern surrounded by healthy tissue. In
290 the en face image, noticeable patterns of uneven dark stretches
291 indicate the presence of tumor. One definite indicator of
292 BCC in OCT images is the reduction of signal intensity.
293The presence of BCC in the en face images in Figs. 5, 6,
294and 7 is manifested in clusters of signal-free dark spots,
295rather than in continuous bounded areas, primarily due to
296the position of BCC tumor spreads across multiple axial layers
297of en face images.
298The second experiment was carried out using samples of
299Case 2. Clinical microscopy images are shown in Fig. 8.
300The purple areas are identified as BCC by the histologist.
301Cross-sectional and en face images taken from this case with
302features associated with BCC are shown in Figs. 9 and 10.
303Various features are detected in the cross-sectional OCT images
304in Fig. 9: (1) sweat ducts identified by a consistent shallow
305shaft, (2) cross-sectional blood capillary showed up as a highly
306reflective circle, and (3) suspected BCC tumors with irregular
307reflectivity contrasts. Other features suspected to be BCC in
308OCT images (detected by an early report using time-domain
309OCT with dynamic focus [22]) can also be seen in images gen-
310erated using the MS-OCT. These features are noticeable in
311Fig. 10 with scattered high-reflectivity areas that exhibit size
312enlargement as we move deeper into depth. BCC tissues are
313usually highly reflective at 1300 nm, leading to dark scattered
314margins surrounded by low-reflectivity tissue. The tissue areas
315that are lacking these random dark patches are identified as
316healthy tissue.
317An immediate practical advantage of en face imaging is
318showing the direction in which tumors metastasize. With each
319en face image displaying the area of BCC in the transverse plane
320in constant intensity, less complicated analysis is required to
321identify the tumors, compared to measuring the reduction
F5:1 Fig. 5. Results of Case 1. Cross-sectional OCT images of eyelid BCC taken from three consecutive transverse slices at the center of the sample.
F5:2 The left, middle, and right slices are each separated by 15 μm. The size of the image is 1.2 mm × 0.8 mm. The arrows show the suspected areas
F5:3 of BCC.
F6:1 Fig. 6. Results of Case 1. En face OCT images of eyelid BCC taken at different depths. The depth was measured from the top of the sample in
F6:2 air. The lateral size of the image is 1.5 mm × 1.5 mm. The arrows show the areas of BCC correlated with histology data.
F7:1 Fig. 7. Results for another region of Case 1. (Left): histology image
F7:2 showing blocks of BCC tumors. (Right): en face OCT image of
F7:3 corresponding region taken at a depth of 780 μm from top of sample
F7:4 (measured in air).
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322 of signal strengths in the cross-sectional OCT images. This fea-
323 ture is particularly important to determine the lateral borders of
324 a BCC tumor adjacent to healthy tissue.
325 The MS-OCT ability to detect the pigmented type of BCC
326 is further evidenced in Case 3. Histology images in Fig. 11
327 show tumor lobules concentrated in pigment surrounded by
328 healthy tissue. Due to the high reflectivity of BCC, the higher
329 concentration of tumor cells blocked light transmission in the
330 tissue, producing a signal-free dark spot in the middle of the
331 cross-sectional OCT image as evidenced by arrows in Fig. 12.
332 This region can be further verified by scanning through dif-
333 ferent layers of the en face images in Fig. 13. As we move further
334 in depth, more common features pointing to potential BCC
335start to unfold. OCT images are placed side by side with his-
336tology images where correlation of tumor features was per-
337formed. In Fig. 11, the depth data from en face images are
338in agreement with the histology data that show structures of
339BCC at approximately 0.5 mm underneath the dermis. En face
340images in Figs. 6, 10, and 13 are in their original form, free
341from any quality adjustment. In the slightly pixelated cross-sec-
342tional OCT images of Figs. 5, 9, and 12, predominant tumor-
343like features remain easily recognizable. Studies have shown
344that image post-processing methods, such as spatial com-
345pounding and de-convolution algorithms, can be used to re-
346duce speckle and enhance signal-to-noise ratio in the
347acquired multilayer images [34,35].
3484. COMMENTS ON TECHNOLOGY
349Based on previous experiments to characterize BCC employing
350OCT systems at two different wavelengths, 830 and 1300 nm,
351we have concluded that 1300 nm was better suited for imaging
352eyelid skin tissue [20]. MS-OCT is an improvement on the
353technique used in two previous setups, using SS-OCT [21]
354and DF- OCT [22].
355The MS-OCT technique proved successful in detecting com-
356plex morphological features of skin in all three specimens im-
357aged. Several skin features that were observed using the DF-
358OCT technique [35] are also present in the MS-OCT en face
359images. These are: (1) nodular structure of abnormal tissue,
360(2) superficial structure of scattered tumor margins, and (3) cross
361section of blood vessels, sweat ducts, and sweat glands in the
362upper dermis.
F8:1 Fig. 8. Histology images of superficial BCC from tissue sample of Case 2. The image on the left shows a tumor exhibiting nested and budding
F8:2 patterns. The lateral size × depth size of the left image is 4 mm × 3 mm. The middle image is an enlarged view of the white boxed region in the left
F8:3 image. The right image is an enlarged view of the black box area in the left image. Magnification: left ×20, middle ×50, and right ×50.
F9:1 Fig. 9. Results of Case 2. Cross-sectional OCT images of eyelid
F9:2 BCC taken from the center of tumor. (1) Sweat ducts. (2) Blood capil-
F9:3 lary under the dermis layer. (3) Suspected areas of BCC. The lateral
F9:4 size × depth size of image is 1.5 mm × 0.6 mm.
F10:1 Fig. 10. Results of Case 2. En faceOCT images of eyelid BCC taken at different depths of 450–950 μm. The depth was measured from the top of
F10:2 sample in air. The arrows show the areas of BCC correlated with histology data. The size of the image is 1.5 mm × 1.5 mm.
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363 BCCs in cross-sectional OCT images can be identified by
364 three main phenomena: (a) abnormal reflectivity profile as we
365 go in depth, (b) obscure regions with clear margins, and
366 (c) repetitive inhomogeneous features different from the sur-
367 rounding cells. Similar morphological features are also used
368 to identify potential BCC candidates in the en face images.
369 A side-by-side comparison with histology images for all three
370 cases further validates the use of these criteria in OCT images
371 with high certainty to locate and detect various types of BCC.
372 In the first two BCC structures, nodal and superficial, the
373 presence of BCC tissue in en face image can be determined
374 from the absence of back reflected signal in a bounded area with
375 clear edges. The presence of some random, low-reflectivity
376 black spots indicate distribution of pigmented BCC structures.
377 The lack of signal from BCC structures can be explained by
378 higher absorption due to their denser structure compared to
379normal tissue [20,21]. This feature is predominately visible
380on OCT systems operating at 1300 nm than on systems using
381shorter wavelengths.
382Conventionally, averaging multiple en face images usually
383improves the signal to noise, allowing better location of
384BCCs otherwise unnoticeable in a cross-sectional OCT image,
385but this is done on the expense of axial resolution.
386The master/slave method can equally be applied to broad-
387band sources, by using a spectrometer, in order to achieve better
388axial resolution [37].
3895. CONCLUSIONS
390In this pilot study, en face images of BCC samples taken from
391three patients were produced using the novel master/slave
392method. In all cases, the suspected BCC regions showed sig-
F12:1 Fig. 12. Results of Case 3. Cross-sectional OCT images of suspected BCC taken at three lateral positions from the center of sample. The arrows
F12:2 show the areas with pigment correlated with histology images. The lateral size × depth size of the image is 1.5 mm × 0.6 mm.
F13:1 Fig. 13. Results of Case 3. En face OCT images of eyelid BCC taken at different depths in the range 425–650 μm. The depth was measured from
F13:2 the top of the sample in air. The arrows show the areas of BCC. The size of the image is 1.5 mm × 1.5 mm.
F11:1 Fig. 11. Histology images of Case 3. Image in (b) shows an enlarged view of the white boxed region in image (a). Image (c) shows an enlarged view
F11:2 of the black box area of image (a). The image (d) shows an enlarged region of image (b) indicating presence of nodular-pigmented-type BCC tumor
F11:3 lobules beneath the epidermis. Magnification: (a) ×20, (b) ×50, (c) ×100, (d) ×200.
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393 nificant reduction in the signal strengths compared to uniform
394 signal reflectivity in neighboring tissues. In some cases, the
395 presence of potential BCC can be identified by irregular scat-
396 tering of high reflectivity dark spots (Fig. 6) and inconsistent
397 light distribution pattern (Fig. 7) in skin tomograms.
398 All features associated with BCC demonstrated in our three
399 previous studies [20–22] are also seen with en face images ob-
400 tained using MS-OCT. Three common types of BCC were
401 identified and fitted well with histology criteria. In particular,
402 nodular BCC are noted with their low reflectivity of light at
403 1310 nm, closely corresponding to BCC on correlation by
404 the histologist following standard laboratory processing.
405 Other subtypes of BCCmay also be picked up by their irregular
406 reflectivity profile in en face images. High accuracy in distin-
407 guishing uncertain tumor lesions from healthy skins was estab-
408 lished [15].
409 A further study has been planned once a portable handheld
410 probe incorporating master/slave technique is manufactured.
411 This will ease the transport of technology for clinical trials
412 at hospitals, allowing imaging to be carried out in real time,
413 in three possible scenarios, involving both in-vitro and in-vivo
414 experiments: (1) pre-surgery diagnosis, (2) intra-operative as-
415 sessment of precise tumor margins, (3) post-surgical side-by-
416 side histology assessment. In-vivo OCT imaging would be pre-
417 ferred for its enhanced clinical value to dermatologists and
418 pathologists [37–39], as the water content and skin optical
419 properties are preserved. We acknowledge possible signal dis-
420 tortions due to in-vitro imaging.
421 The use of the MS-OCT technique has allowed en face im-
422 ages to display noticeable BCC features in real time. With no
423 further image processing required, rapid assessment of BCC
424 extent and surgical margins in excised skin specimens can be
425 carried out, allowing for enhanced management of patients
426 in the clinical setting.
427 This is a preliminary study to assess the values of the en face
428 display in diagnosing BCC. The MS technique is ideally suited
429 to deliver such display as the image is assembled directly while
430 laterally scanning with no need to wait for a whole assembly of
431 A-scans to be subsequently cut.
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